Real-time enrollment status for this pulmonary hypertension associated with hfpef clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 12:38 AM UTC
| NCT Number | NCT07288398 |
| Recruiting Status | Recruiting |
| Condition | Pulmonary Hypertension Associated With HFpEF |
| Phase | PHASE3 |
| Target Enrollment | 540 participants |
| Active Locations | 46 sites in the US |
| Sponsor | Tenax Therapeutics, Inc. |
| Last Updated on CT.gov | August 19, 2026 (1 week ago) |
As of August 31, 2026: Clinical trial NCT07288398 is currently recruiting participants. This phase3 study for pulmonary hypertension associated with hfpef is actively seeking new participants at 46 locations across the United States. The study is sponsored by Tenax Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07288398 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 46 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07288398 was last updated 1 week ago (August 19, 2026). HelloStudys verifies this status automatically.